Skip to content

272BIO: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

272BIO

BE 0762.638.249
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€631,558
2024 · -€457,209-€174,349
Equity
-€225,308
2024 · €406,250-€631,558
Cash
€350,764
2024 · €1.1m-€781,628
Balance sheet total
€709,601
2024 · €1.6m-€871,469

Largest movements

2024 to 2025
Assets
  • Cash -€781,628

    down €781,628 (-69.0%), from €1.1m to €350,764

    mainly Net result for the year (-€631,558) and Other debts (-€307,907)

  • Receivables within one year -€68,284

    down €68,284 (-52.3%), from €130,617 to €62,333

    of which Trade receivables: -€71,576

  • Tangible fixed assets -€45,508

    down €45,508 (-14.8%), from €307,113 to €261,604

    of which Plant, machinery and equipment: -€58,312

Equity and liabilities
  • Profit (loss) carried forward -€631,558

    down €631,558 (-78.4%), from -€805,750 to -€1.4m

  • Other debts -€307,907

    down €307,907 (-33.2%), from €926,462 to €618,555

  • Accrued charges and deferred income +€79,167

    new in 2025: €79,167

  • Trade debts -€44,988

    down €44,988 (-22.4%), from €200,776 to €155,788

  • Tax, wage and social debts +€33,818

    up €33,818 (+71.1%), from €47,581 to €81,399

    of which Remuneration and social security: +€30,171

Income statement
  • Staff costs +€184,489

    up €184,489 (+45.5%), from €405,850 to €590,340

  • Gross operating margin +€86,581

    up €86,581 (+490.0%), from €17,671 to €104,252

  • Other operating charges +€44,351

    up €44,351 (+12967.3%), from €342 to €44,693

  • Depreciation +€41,923

    up €41,923 (+126.5%), from €33,153 to €75,076

  • Financial charges -€9,114

    down €9,114 (-25.2%), from €36,149 to €27,035

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€457,209
Gross operating margin +€86,581
Staff costs -€184,489
Depreciation -€41,923
Other operating charges -€44,351
Financial income +€2,471
Financial charges +€9,114
Taxes -€1,752
Result 2025 -€631,558

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€742,060
Investment -€39,568
Financing €0
Cash 2024 €1.1m
Net result for the year -€631,558
Depreciation +€75,076
Receivables within one year +€68,284
Deferred charges and accrued income -€13,952
Trade debts -€44,988
Tax, wage and social debts +€33,818
Other debts -€307,907
Accrued charges and deferred income +€79,167
Investment in fixed assets (net) -€39,568
Cash 2025 €350,764
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,581,070 €709,601 -€871,469 -55.1%
Fixed assets 21/28 €315,984 €280,475 -€35,508 -11.2%
Tangible fixed assets 22/27 €307,113 €261,604 -€45,508 -14.8%
Plant, machinery and equipment 23 €299,795 €241,483 -€58,312 -19.5%
Furniture and vehicles 24 €7,318 €9,055 +€1,737 +23.7%
Other tangible fixed assets 26 - €11,067 +€11,067
Financial fixed assets 28 €8,871 €18,871 +€10,000 +112.7%
Current assets 29/58 €1,265,086 €429,126 -€835,960 -66.1%
Amounts receivable within one year 40/41 €130,617 €62,333 -€68,284 -52.3%
Trade receivables 40 €96,174 €24,598 -€71,576 -74.4%
Other amounts receivable 41 €34,443 €37,735 +€3,292 +9.6%
Cash at bank and in hand 54/58 €1,132,392 €350,764 -€781,628 -69.0%
Deferred charges and accrued income 490/1 €2,077 €16,029 +€13,952 +671.6%
Total equity and liabilities 10/49 €1,581,070 €709,601 -€871,469 -55.1%
Equity 10/15 €406,250 -€225,308 -€631,558
Contributions 10/11 €1,212,000 €1,212,000 = 0.0%
Profit (loss) carried forward 14 -€805,750 -€1,437,308 -€631,558 -78.4%
Amounts payable 17/49 €1,174,819 €934,909 -€239,911 -20.4%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €1,174,819 €855,742 -€319,077 -27.2%
Trade debts 44 €200,776 €155,788 -€44,988 -22.4%
Suppliers 440/4 €200,776 €155,788 -€44,988 -22.4%
Taxes, remuneration and social security 45 €47,581 €81,399 +€33,818 +71.1%
Taxes 450/3 €3,443 €7,090 +€3,647 +105.9%
Remuneration and social security 454/9 €44,139 €74,309 +€30,171 +68.4%
Other amounts payable 47/48 €926,462 €618,555 -€307,907 -33.2%
Accrued charges and deferred income 492/3 - €79,167 +€79,167
Remuneration, social security and pensions 62 €405,850 €590,340 +€184,489 +45.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €33,153 €75,076 +€41,923 +126.5%
Other operating charges 640/8 €342 €44,693 +€44,351 +12967.3%
Gross operating margin 9900 €17,671 €104,252 +€86,581 +490.0%
Operating profit (loss) 9901 -€421,675 -€605,857 -€184,182 -43.7%
Financial income 75/76B €615 €3,086 +€2,471 +401.7%
Recurring financial income 75 €615 €3,086 +€2,471 +401.7%
Financial charges 65/66B €36,149 €27,035 -€9,114 -25.2%
Recurring financial charges 65 €36,149 €27,035 -€9,114 -25.2%
Profit (loss) for the period before taxes 9903 -€457,209 -€629,806 -€172,597 -37.8%
Income taxes 67/77 €0 €1,752 +€1,752
Profit (loss) for the period 9904 -€457,209 -€631,558 -€174,349 -38.1%
Profit (loss) for the period to be appropriated 9905 -€457,209 -€631,558 -€174,349 -38.1%

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.